High tech medicine
High-tech medical interventions are placed in an area of tension due to a short life-cycle, budget constraints and efficacy/ safety aspects. These AIHTA reports support decision-making based on the best available evidence.
Research projects
Long-term sequelae after SARS CoV-2 disease
Project leaders: Sarah Wolf
Project team: Sarah Wolf, Judit Erdös
Duration: April 2021 – November 2021
Language: English (with German summary)
Publications:
HTA Project Report No 135a: https://eprints.aihta.at/1321
HTA Project Report No. 135b: https://eprints.aihta.at/1342
Evaluation of individual medical procedures - MEL 2021
Project leaders: Gregor Goetz
Project co-operation: AIHTA staff for individual reviews
Duration: November 2020 – March 2021
Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia – German Summary of the EUnetHTA OCTA27 Assessment
Project leaders: Judit Erdös
Project team: Judit Erdös
& EUnetHTA partners (RER, VASPVT, SNHTA, Azienda Zero)
Duration: May 2020 – January 2021
Language: English with German summary
Publication: DSD No. 129: https://eprints.aihta.at/1328/
HSS/ Horizon Scanning for Covid19
Project leaders: Claudia Wild
Project team: All employees of the AIHTA
Coordination (vaccinations): Gregor Götz
Coordination (drugs): Sarah Wolf
Duration: March 2020 – open
Language: English and German
Publication: Policy Brief No. 002: http://eprints.aihta.at/1234/
Evaluation of individual medical procedures - MEL 2019
Project co-operation: LBI-HTA staff for individual reviews
Duration: November 2018– März 2019
POCT/ Point of Care Tests: D-Dimer and Troponin
Project leaders: Gregor Goetz, Louise Schmidt
Project team: Gregor Goetz, Judit Erdös, Louise Schmidt
Duration: April 2019 - October 2019
Suggested by: Representatives of federal states
Language: English, EUnetHTA REA
Publication: LBI-HTA Project report No. 124: https://eprints.aihta.at/1224/
Wearable cardioverter-defibrillator (WCD) therapy as prevention of sudden cardiac death in patients at risk - Update 2018
Project team: Gregor Goetz
Project leaders: Tom Jefferson, Claudia Wild
Project team: Emilio Chiarolla, Massimiliano Orso, Gregor Goetz, Michal Stanak
This project will be conducted collaboratively with the Italian National Agency for Regional Health Services (AGENAS).
Duration: July 2018 – November 2018
Suggested by: Representatives of federal states in Austria
Language: English (Executive summary in German)
Publication: Decision Support Document No. 103/Update 2018: https://eprints.aihta.at/1186
Natalizumab as treatment for Multiple Sclerosis: a systematic review
Duration: June 2018 – September 2018
Language: English
Publication: LBI-HTA Project report No. 112: https://eprints.aihta.at/1190/
Technology Forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption
Project leaders: Claudia Wild
Project team: Claudia Eder
Duration: August 2018 – November 2018
Language: English
Publication: Article
Inhalation sedation with nitrous oxide in dentistry
Duration: April 2018 – November 2018
Topic submitted by: Federation of Austrian Social Security Institutions
Language: German
Publication: LBI-HTA Project report No. 105: https://eprints.aihta.at/1182/